Chembio Diagnostics (Nasdaq: CEMI) announced the closing of its previously announced underwritten public offering of 1,200,000 shares of its common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE